1.
Association between the changes in renal function and serum uric acid levels during multifactorial intervention and clinical outcome in patients with metabolic syndrome. A post hoc...
by Athyros, Vassilios G
Current medical research and opinion, 2011-08, Vol.27 (8), p.1659-1668
2.
Multiplex proteomics for prediction of major cardiovascular events in type 2 diabetes
by Nowak, Christoph
Diabetologia, 2018-05-24, Vol.61 (8), p.1748-1757
3.
Association between anxiety and mortality in patients with coronary artery disease: A meta-analysis
by Celano, Christopher M., MD
The American heart journal, 2015, Vol.170 (6), p.1105-1115
4.
Relation of Cardiac Complications in the Early Phase of Community-Acquired Pneumonia to Long-Term Mortality and Cardiovascular Events
by Cangemi, Roberto, MD
The American journal of cardiology, 2015, Vol.116 (4), p.647-651
5.
The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controll...
by Baigent, Colin, Prof
The Lancet (British edition), 2011, Vol.377 (9784), p.2181-2192
6.
Long-Term Cardio- and Cerebrovascular Events in Patients With Primary Aldosteronism
by Mulatero, Paolo
The journal of clinical endocrinology and metabolism, 2013-12, Vol.98 (12), p.4826-4833
7.
Initial Combination Therapy Reduces the Risk of Cardiovascular Events in Hypertensive Patients: A Matched Cohort Study
by Gradman, Alan H
Hypertension (Dallas, Tex. 1979), 2013-02, Vol.61 (2), p.309-318
8.
Design and Rationale for the Effects of Ticagrelor and Clopidogrel in Patients with Peripheral Artery Disease (EUCLID) Trial
by Berger, Jeffrey S., MD, MS
The American heart journal, 2015, Vol.175, p.86-93
9.
The COURAGE to face ISCHEMIA: Applying data from randomized studies to real-life
by Tsaban, Gal
Trends in cardiovascular medicine, 2021-11
10.
Association of cytochrome P450 2C192 polymorphism with clopidogrel response variability and cardiovascular events in Koreans treated with drug-eluting stents
by Oh, Il-Young
Heart (British Cardiac Society), 2012-01, Vol.98 (2), p.139-144
11.
Cardiovascular Protection With Antihypertensive Drugs in Dialysis Patients: Systematic Review and Meta-Analysis
by Agarwal, Rajiv
Hypertension (Dallas, Tex. 1979), 2009-05, Vol.53 (5), p.860-866
12.
Concomitant use of clopidogrel and proton pump inhibitors: impact on platelet function and clinical outcome- a systematic review
by Focks, Jeroen Jaspers
Heart, 2013-04, Vol.99 (8), p.520-50
13.
Left Atrial Size and Risk of Major Cardiovascular Events During Antihypertensive Treatment: Losartan Intervention for Endpoint Reduction in Hypertension Trial
by Gerdts, Eva
Hypertension (Dallas, Tex. 1979), 2007-02, Vol.49 (2), p.311-316
14.
Blood pressure targets in type 2 diabetes. Evidence against or in favour of an aggressive approach
by Mancia, Giuseppe
Diabetologia, 2018-01-25, Vol.61 (3), p.517-525
15.
Association of cardio-ankle vascular index and future major adverse cardiovascular events in older adults living with HIV
by Rerkasem, Amaraporn
AIDS care, , Vol.ahead-of-print (ahead-of-print), p.1-9
16.
Ethnic Differences in the Degree of Morning Blood Pressure Surge and in Its Determinants Between Japanese and European Hypertensive Subjects: Data From the ARTEMIS Study
by Hoshide, Satoshi
Hypertension (Dallas, Tex. 1979), 2015-10, Vol.66 (4), p.750-756
17.
Predictive value of electrocardiographic left ventricular hypertrophy in the general population: A meta-analysis
by You, Zhigang
Journal of electrocardiology, 2020-09, Vol.62, p.14-19
18.
Effects of Niacin Combination Therapy With Statin or Bile Acid Resin on Lipoproteins and Cardiovascular Disease
by Zambon, Alberto, MD
The American journal of cardiology, 2014, Vol.113 (9), p.1494-1498
19.
Pneumococcal polysaccharide vaccine associated with reduced lengths of stay for cardiovascular events hospital admissions
by Ren, Shu
Vaccine, 2018-11-26, Vol.36 (49), p.7520-7524
20.
Central Haemodynamics and Prediction of Cardiovascular Events in Patients With Erectile Dysfunction
by Vlachopoulos, Charalambos
American journal of hypertension, 2017-03-01, Vol.30 (3), p.249-255
